Pardes poaches former Dermira CEO Thomas Wiggans amid rocky ride at stock market
Pardes poaches former Dermira CEO Thomas Wiggans amid rocky ride [...]
Pardes poaches former Dermira CEO Thomas Wiggans amid rocky ride [...]
Pardes poaches former Dermira CEO Wiggans amid rocky ride at [...]
Roche plans 4-year late-stage trial for Alzheimer’s candidate while awaiting [...]
Atlas lands $450M fund to build fresh batch of biotechs [...]
AstraZeneca, Sanofi reveal mixed hand in high-stakes RSV game, with [...]
SAB’s shares drop 45% after NIH ditches COVID-19 trial due [...]
Pfizer revs up to leave GSK in the dust as [...]
FDA slaps hold on Finch’s C. diff med to get [...]
RedHill’s second-try COVID pill staves off hospitalization in phase 2 [...]
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer’s and [...]